Literature DB >> 12887194

Evaluation of the non-temperature-sensitive field clonal isolates of the Mycoplasma synoviae vaccine strain MS-H.

Amir H Noormohammadi1, Jillian F Jones, Karl E Harrigan, Kevin G Whithear.   

Abstract

The live attenuated temperature-sensitive (ts+) Mycoplasma synovia (MS) strain, MS-H, is used as a vaccine in a number of countries to control virulent MS infection in commercial chicken flocks. Nine out of 50 isolates made from flocks vaccinated with MS-H were found to have lost the ts+ phenotype of the original vaccine strain. In order to examine the influence of the ts- phenotype on virulence of the isolates, four of the ts- isolates, the MS-H vaccine, and the vaccine parent strain 86079/7NS were administered by aerosol in conjunction with infectious bronchitis virus to 3-wk-old specific-pathogen-free chickens. The four ts- clones induced only minimal air sac lesions that were not different in severity from those caused by MS-H vaccine; however, the vaccine parent strain 86079/7NS caused air sac lesions that were significantly greater than those of MS-H and all ts- clones. The vaccine parent strain 86079/7NS and two of the ts- clones were recovered from the air sacs of the respectively infected chickens whereas the MS-H vaccine and two other ts- clones were not. Three of the ts- isolates caused increased tracheal mucosal thicknesses that were significantly greater than those from birds inoculated with MS-H, and one caused increased tracheal mucosal thicknesses that were significantly less than those from birds inoculated with 86079/7NS. In conclusion, unlike the MS-H vaccine, the MS-H ts- clones were associated with minor changes in tracheal mucosa; however, unlike the vaccine parent strain, they did not induce lesions in the air sacs. These results suggest that factors other than ts+ phenotype are involved in the attenuation of the MS-H vaccine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887194     DOI: 10.1637/0005-2086(2003)047[0355:EOTNFC]2.0.CO;2

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  6 in total

1.  Laboratory investigations into the origin of Mycoplasma synoviae isolated from a lesser flamingo (Phoeniconaias minor).

Authors:  Salvatore Catania; Federica Gobbo; Ana S Ramirez; Davide Guadagnini; Elisa Baldasso; Maria Luisa Moronato; Robin A J Nicholas
Journal:  BMC Vet Res       Date:  2016-03-12       Impact factor: 2.741

2.  Isolation and Antimicrobial Sensitivity of Mycoplasma synoviae and Mycoplasma gallisepticum from Vaccinated Hens in Mexico.

Authors:  Víctor M Petrone-Garcia; Guillermo Tellez-Isaias; Fernando Alba-Hurtado; Christine N Vuong; Raquel Lopez-Arellano
Journal:  Pathogens       Date:  2020-11-07

3.  High-resolution melting-curve analysis of obg gene to differentiate the temperature-sensitive Mycoplasma synoviae vaccine strain MS-H from non-temperature-sensitive strains.

Authors:  Muhammad A Shahid; Philip F Markham; Marc S Marenda; Rebecca Agnew-Crumpton; Amir H Noormohammadi
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

4.  Genome analysis of Mycoplasma synoviae strain MS-H, the most common M. synoviae strain with a worldwide distribution.

Authors:  Ling Zhu; Muhammad A Shahid; John Markham; Glenn F Browning; Amir H Noormohammadi; Marc S Marenda
Journal:  BMC Genomics       Date:  2018-02-02       Impact factor: 3.969

5.  Preliminary comparative analysis of the genomes of selected field reisolates of the Mycoplasma synoviae vaccine strain MS-H reveals both stable and unstable mutations after passage in vivo.

Authors:  Somayeh Kordafshari; Pollob Shil; Marc S Marenda; Olusola M Olaogun; Barbara Konsak-Ilievski; Jillian Disint; Amir H Noormohammadi
Journal:  BMC Genomics       Date:  2020-08-28       Impact factor: 3.969

6.  Application of different laboratory techniques to monitor the behaviour of a Mycoplasma synoviae vaccine (MS-H) in broiler breeders.

Authors:  M L Moronato; M Cecchinato; G Facchetti; M Mainenti; F Gobbo; S Catania
Journal:  BMC Vet Res       Date:  2018-11-20       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.